Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2007
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857466A2 Soluble interleukin-20 receptor
11/21/2007EP1857460A2 New metal complexes, method of preparing them and therapeutic uses for them
11/21/2007EP1857447A1 Ppar-activating compound
11/21/2007EP1857444A1 Tetrahydroisoquinoline compound and medicinal use thereof
11/21/2007EP1857443A2 Therapeutic morpholino-substituted compounds
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857114A1 Particle and preparation containing the particle
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1856155A2 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
11/21/2007EP1856153A1 Ykl-40 monoclonal antibodies
11/21/2007EP1856116A1 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially tyrosine kinase and raf kinase modulators
11/21/2007EP1856107A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists
11/21/2007EP1856092A1 6-heteroaryl-1,2,3,4,4a,10b-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders
11/21/2007EP1856074A2 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents
11/21/2007EP1856062A1 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine mediated diseases
11/21/2007EP1856058A2 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
11/21/2007EP1856040A2 Novel lipoxygenase inhibitors
11/21/2007EP1856031A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
11/21/2007EP1855682A2 Aminopterin dosage forms and methods for inflammatory disorders
11/21/2007EP1623711B1 External patch containing estrogen and/or progestogen
11/21/2007EP1578425B1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/21/2007EP1572653B1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants
11/21/2007EP1458383B1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
11/21/2007EP1431284B1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
11/21/2007EP1405639B1 Use of sodium channel blocking compounds and aspirin in manufacturing drugs for producing synergistic analgesic effect in mammals
11/21/2007EP1363594B1 Cosmetic formulations containing flavonoid derivatives
11/21/2007EP1319064B1 Gsk3 polypeptides
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007EP1056728B1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
11/21/2007EP0981374B1 Sustained-release delayed gels
11/21/2007EP0842196B1 Cell adhesion inhibitors
11/21/2007CN101076354A Carrier used for medicine giving for intestine
11/21/2007CN101076333A Pyrazolo-heteroaryl compounds useful to treat TNF-alpha and IL-1 mediated diseases
11/21/2007CN101076329A Methods for purifying trans-(-)-delta;9-tetrahydrocannabinol and trans-(+)-delta;9-tetrahydrocannabinol
11/21/2007CN101076325A Medicinal composition of edible carboxylic-acid and/or its acid salts and caffeine and non-drug addiction coffee
11/21/2007CN101074447A Method for producing paeonin metabolite-I by short lactobacillin fermentation
11/21/2007CN101074259A Saponin compound, its production and use
11/21/2007CN101074220A Dehydroandrographolide succinate semialdehyde compound, its production and medicine
11/21/2007CN101074210A Pharmaceutically active isoindoline derivatives
11/21/2007CN101074190A Alpha-substituted 3,5-bisubsituted acrylic acid and its derivative, preparation and use
11/21/2007CN101073662A Qianwu capsules for stretching tendon and analgesia
11/21/2007CN101073644A Chinese-medicinal liquor for treating rheumatosis
11/21/2007CN101073635A Paste
11/21/2007CN101073633A Chinese-herb medicinal preparation for treating various rheumatalgia, neuralgia and hyperosteogeny
11/21/2007CN101073630A Externally-applied cream for treating various diseases
11/21/2007CN101073625A Medicinal composition with anti-infective and anti-inflammatory functions
11/21/2007CN101073621A Medicinal composition for treating rheumatic pain
11/21/2007CN101073595A Glycyrrhiza total flavonoid and total saponin extract and its production
11/21/2007CN101073590A Muxiang total lactone extract and its production
11/21/2007CN101073589A Freeze-drying powder injection for treating calor febrilis and its production
11/21/2007CN101073571A Medicinal composition for treating cold wet numbness and its production
11/21/2007CN101073563A Chiral composition containing dextrothyroxine buprofenli and levomethadyl cysteliqin and its double slow-releasing tablet
11/21/2007CN101073559A Adamantine rattan slow release-controlled agent and its production
11/21/2007CN101073398A Yellow-peach can
11/21/2007CN101073365A Lily health-care heat-clearing tea and its production
11/21/2007CN101073359A Thirst-wasting heatstroke tea
11/21/2007CN101073352A Anti-inflammatory tea with throat-clearing function
11/21/2007CN101073347A Health-care tea soup with heat-clearing and antitussive functions
11/21/2007CN101073333A Multi-flavor biscuit
11/21/2007CN100349887C Substituted 4-aryl-4H-pyrrolo[2,3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2007CN100349884C 3-phenylfuran-2-one derivatives as cox-2 inhibitor
11/21/2007CN100349862C 大麻素受体配体 Cannabinoid receptor ligands
11/21/2007CN100349627C Medical devices containing rapamycin analogs
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297715 PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
11/20/2007US7297703 Macrolides
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297523 Human elongase genes and uses thereof
11/20/2007US7297353 For oral administration, injection and topical application; can eliminate the aseptic inflammations, edema, adhesion caused by aseptic inflammations, and stubborn pain, complex body disorders caused by aseptic inflammation, edema and adhesion
11/20/2007US7297332 Protease, a gene therefor and the use thereof
11/20/2007CA2451754C Thienothiazine compounds having anti-inflammatory and analgesic activities and their preparation methods and the use thereof
11/20/2007CA2344652C Carboxymethylgalactose derivatives
11/20/2007CA2262409C Modified tie-2-receptor ligands
11/15/2007WO2007130780A2 Benzimidazole modulators of vr1
11/15/2007WO2007130383A2 Compositions and treatments using pyridazine compounds and secretases
11/15/2007WO2007129963A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129962A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129743A1 Anti-inflammatory composition
11/15/2007WO2007129646A1 Macrolide derivative
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007129406A1 Degranulation inhibitor
11/15/2007WO2007129188A1 Cyclopropanecarboxamide compound
11/15/2007WO2007129111A1 Diazepine derivatives as 5-ht2a antagonists
11/15/2007WO2007129048A1 Thiazole derivatives as inhibitors of p13 kinase
11/15/2007WO2007129040A1 p38 MAP KINASE INHIBITORS
11/15/2007WO2007129036A1 Inhibitors of p38 map kinase
11/15/2007WO2007129020A1 Pyrimidine derivatives useful as dhfr inhibitors
11/15/2007WO2007129005A1 Aminoacid derivatives of thiazoles as inhibitors of pi3 kinase
11/15/2007WO2007128752A1 Pyridyl compounds
11/15/2007WO2007128413A1 Pharmaceutical combination comprising 3- ( 3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol
11/15/2007WO2007128412A1 Pharmaceutical combination comprising 3- (3-dimethylamin0-1-ethyl-2-methyl-pr0pyl) -phenol and an nsaid
11/15/2007WO2007128056A1 Methods and composition for treatment of inflammatory pain
11/15/2007WO2007112968A3 Anti-inflammatory polymer
11/15/2007WO2007084560A8 INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH
11/15/2007WO2007062167A3 Method of modulating stress-activated protein kinase system
11/15/2007WO2006121390A8 Benzoic acid derivatives that are modulators or agonists of glyr
11/15/2007WO2003106666A3 Protein c variants with altered properties
1 ... 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 ... 1272